Stem Cell Transplant Complications Withdrawn Phase 4 Trials for Sulfur hexafluoride (DB11104)

IndicationStatusPhase
DBCOND0081111 (Stem Cell Transplant Complications)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03963999Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant PatientsDiagnostic